Safety Study of Black Cohosh Use by Postmenopausal Women on the Liver
CR-LIVER
Influence of Black Cohosh (Cimicifuga Racemosa) Use by Postmenopausal Women on Total Hepatic Perfusion and Liver Functions
1 other identifier
interventional
100
1 country
1
Brief Summary
Black Cohosh extract is a form of phytoestrogen (estrogen of plant origin) that is effective in controlling bothersome hot flushes, while avoiding the dangers of using hormones. Recent case reports pointed to potential toxicity of black cohosh on the liver. The investigators are trying to verify or refute such allegations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 19, 2008
CompletedFirst Posted
Study publicly available on registry
November 20, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2009
CompletedAugust 3, 2009
July 1, 2009
11 months
November 19, 2008
July 31, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect on hepatic perfusion and liver functions
12 months
Secondary Outcomes (1)
Efficacy and tolerability
12 months
Study Arms (1)
black cohosh extract, liver
EXPERIMENTAL100 postmenopausal women
Interventions
40 mg of Cimicifuga racemosa extract daily dor 12 months
Eligibility Criteria
You may qualify if:
- an age over 40 years
- with a lapse of one year after the last menstruation
- symptomatic women without gynecological illness
- after naturally occurring menopause
- had never used hormonal therapy or had stopped using them for \>6 months
- accepting to participate after receiving adequate description of the study
- accessible for regular follow-up.
You may not qualify if:
- vaginal bleeding
- active or chronic liver disease and /or abnormal liver functions
- present or past thromboembolic disease
- present or past neoplasia of the breast or uterus
- an endometrial thickness \>5 mm by TVS
- use of alternative or complementary medicines or herbs for menopausal symptoms within the previous three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dept. Obstetrics and Gynecology, Assiut University
Asyut, Asyut Governorate, 71516, Egypt
Related Publications (2)
Mahady GB, Low Dog T, Barrett ML, Chavez ML, Gardiner P, Ko R, Marles RJ, Pellicore LS, Giancaspro GI, Sarma DN. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause. 2008 Jul-Aug;15(4 Pt 1):628-38. doi: 10.1097/gme.0b013e31816054bf.
PMID: 18340277BACKGROUNDChow EC, Teo M, Ring JA, Chen JW. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust. 2008 Apr 7;188(7):420-2. doi: 10.5694/j.1326-5377.2008.tb01691.x. No abstract available.
PMID: 18393750BACKGROUND
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
AHMED M NASR, MD
ASSIUT UNIVERSITY, EGYPT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 19, 2008
First Posted
November 20, 2008
Study Start
January 1, 2008
Primary Completion
December 1, 2008
Study Completion
January 1, 2009
Last Updated
August 3, 2009
Record last verified: 2009-07